Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. - Wikidata - awgldk - TriplyDB

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

http://www.wikidata.org/entity/Q38019412

about

Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer Hallmarks of glycosylation in cancer Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1 Glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer.Hypoxia-inducible factor 2 alpha is essential for hepatic outgrowth and functions via the regulation of leg1 transcription in the zebrafish embryo Soy and breast cancer: focus on angiogenesis.Characterizing the Genetic Basis for Nicotine Induced Cancer Development: A Transcriptome Sequencing Study.Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma.Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice.Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1.Self-assembled glycopeptide nanofibers as modulators of galectin-1 bioactivity.Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course.Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling.Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer.Engineering galectin-glycan interactions for immunotherapy and immunomodulation Altered tumor-cell glycosylation promotes metastasis.Deregulation of annexin-A1 and galectin-1 expression in precancerous gastric lesions: intestinal metaplasia and gastric ulcer Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma.HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.Galectin-1 inhibitors and their potential therapeutic applications: a patent review.Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies.MGL induces nuclear translocation of EndoG and AIF in caspase-independent T cell death.Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.Comparative proteomic analysis of fibrosarcoma and skin fibroblast cell lines.Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers.A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme.Glycodendrimers: tools to explore multivalent galectin-1 interactions Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard.Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers Role of Galectins in Multiple Myeloma.How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.TrkB-Target Galectin-1 Impairs Immune Activation and Radiation Responses in Neuroblastoma: Implications for Tumour Therapy.Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.

P2860

Q26744538-C45B0E0F-1141-426E-A2D2-962F54D1C463 Q26752363-D7955951-D0B1-4E9A-84CC-8E0D7EC3B184 Q28069952-11464D8C-B2C3-4B6E-AD58-E2934AD9D6E1 Q28075523-AAF8D2A7-DB8E-4E35-BC2F-88C9B4F57D5F Q33659849-8FD6DA8C-1D79-4684-B429-BF57DE9E20CB Q33695064-649FB16F-2E38-481D-BA96-FC6F65C00616 Q33856252-F1521929-CF3B-4D64-A980-F5AA24ADC4AC Q34477740-E18D546E-0D1D-456F-8B96-A61040C9A09C Q34794845-E5DBD2B6-EA6E-4EFA-9F94-39DED7139BAF Q34797866-F72BD1C0-D830-424A-9513-D392DC3F1879 Q35606014-A9FADB67-40A1-4DBC-94DF-810C2A227156 Q35713332-C00591A2-9989-4240-A04B-88647EB860EB Q36175773-AD3D17F8-F45F-4FE2-9267-26855FBDD267 Q36821077-5342C715-E977-4E98-AE38-C5E8041B1D52 Q36866377-D1E53B4C-C569-4DF6-BA26-855F859E9B94 Q36879539-2A4B1A1C-36D7-4AC6-9312-EA0377A153A6 Q37107168-2F0BDBD2-3C53-4133-9F4F-FCB58E15106E Q37581540-C1BDA694-4849-4B6F-B697-4148BCFE2F0D Q37639722-3AC5054E-CE49-4682-8DAD-779E5ADB892B Q37703390-A64DA120-525B-4502-9180-096252F12C6A Q38112399-D23B9B70-6ABE-4896-A07B-DAB5565C20CB Q38174863-FEEBCE9B-C1D1-41AF-AB0A-737846241486 Q38315100-3DBEB4C6-65CF-4C0C-B4E9-BCB3C904E6A4 Q38763827-50D56144-9615-42E2-8F44-24307E551096 Q38764048-520D2366-E383-4822-829A-20C3ACE13021 Q38779512-7ED8F81F-807E-4A76-8E89-B39B8E1D4479 Q38820318-F78F5871-C740-4681-8716-FF4CB36E3F07 Q38839374-4E3A2435-5279-4A4B-BC43-15B57B5DDB67 Q38932655-95A180C5-94B1-4917-85E3-174640188508 Q38951748-6AFCF319-D8EC-427A-BD1A-6DF1A1FD11E6 Q41079477-B56F3356-1D93-4F56-84F5-3D0F3FAF4C9B Q41481825-ADF7EBFD-58CC-40F3-8856-F9521803F695 Q41925209-1A614CCB-7628-4AD9-AC80-9A9F2976DE8B Q42030543-AC942835-6083-408E-8DFD-901AB4DFFB46 Q42378844-6DF85C07-0872-41BD-B173-27A5E7AA6E4B Q47282400-90E1E051-373A-4F3E-8EF7-D87EB1100E62 Q47601253-F779CC78-6B3C-431E-A1F9-8C7F309EF37D Q48270428-9E1A50B0-5A4B-4B26-A8B1-DD265DA8F285 Q52369537-ABADB3E2-E80E-4CED-9504-BA23DBD17997 Q53059094-7F44AFC4-5132-4B83-BB12-C40B4C85F8C7

P2860

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

http://www.wikidata.org/entity/Q38019412

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

@en

type

label

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

@en

prefLabel

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

@en

P1433

Q38019412-4DFD943E-659E-497A-80CC-A5F29B0D8E93

P1476

Q38019412-B376560A-AC15-4D90-8549-B72FC192E943

P2093

Q38019412-07655477-19FE-4238-B856-85F91E6E7FD5

Q38019412-7E94F7C3-3564-4297-8C4C-8C8FE6CD02B2

Q38019412-83E29153-5394-4B9F-B0EC-FD4F8F32694F

Q38019412-A4A6ADB6-5D93-465E-BDC4-878EC71A0821

Q38019412-DA10596E-6BAD-4B53-B4F3-515EB95BBAE0

P2860

Q38019412-06CD9357-3721-4E5B-93CE-B7619C9F6731

Q38019412-071399E2-DAF4-44BC-B50F-DD22616DF3BA

Q38019412-09DEE7E6-C6B3-4229-BEE3-07658DAAC7AE

Q38019412-0ABCF1B7-CBD4-45AD-82BD-3D6E9E622486

Q38019412-0B9D6263-4D3D-4B90-A791-CDD82ED55506

Q38019412-0FC57D85-6ED8-4616-AA9B-FFA520636DE3

Q38019412-10DBA682-12F6-4C5C-A864-60E9F265081E

Q38019412-16308CB2-E006-46A4-B51E-2B973F19F898

Q38019412-19D6C8B8-8DF5-4FD9-AF9A-801A36668843

Q38019412-19F2A388-8DF7-4193-8E43-F0822A55D1BF

P2888

Q38019412-92566912-A054-4EF8-8BF9-1D46A12BCFA2

P304

Q38019412-942A4F1B-1A94-40C6-A8EA-EC8EA84D9736

P31

Q38019412-A549A13F-7A5F-4BD8-8458-513D73C5ADB5

P356

Q38019412-698E926E-7E65-4B91-9F79-FBD9EF221820

P433

Q38019412-8ECB97C8-6CD3-4936-B0D8-47799EDB69D8

P478

Q38019412-8905152E-EDDC-4925-9F3C-22BF182D1308

P50

Q38019412-3A96BB92-A6EA-40B3-98E8-85DC2266BA96

Q38019412-6333F397-6F1F-4B43-8BB9-CD0EB3CBA65A

Q38019412-80F90885-FA5F-4BE3-9C4E-AE765A866567

P577

Q38019412-B15E0B0D-D115-44F1-86B8-4858EEB13194

P5875

Q38019412-32F0F113-4E22-4F51-84D2-7FF32F6640F8

P6179

Q38019412-9FE99147-082E-45CB-9878-C90C230E7498

P698

Q38019412-1DED6EE1-6329-40E3-BE7A-C442437EB2B6

P356

S10555-012-9388-2

P1433

Cancer and Metastasis Reviews

P1476

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment

@en

P2093

Elwyn Gabutero

http://www.w3.org/2001/XMLSchema#string

Kimberley Stannard

http://www.w3.org/2001/XMLSchema#string

Koichi Ito

http://www.w3.org/2001/XMLSchema#string

Selda Onturk

http://www.w3.org/2001/XMLSchema#string

Shi-Yong Neo

http://www.w3.org/2001/XMLSchema#string

P2860

Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling

Expression of galectin-3 modulates T-cell growth and apoptosis

C4.4A as a candidate marker in the diagnosis of colorectal cancer

Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.

Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer.

Molecular pathways: hypoxia response in immune cells fighting or promoting cancer

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model

Taloside inhibitors of galectin-1 and galectin-3

Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

P2888

s10555-012-9388-2

P304

763-778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10555-012-9388-2

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J. Ralph

Helen Blanchard

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227176002

http://www.w3.org/2001/XMLSchema#string

P6179

1022129966

http://www.w3.org/2001/XMLSchema#string

P698

22706847

http://www.w3.org/2001/XMLSchema#string